- Home
- TERN vs ACTG Comparison
TERN vs ACTG Comparison
Compare TERN & ACTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TERN
- ACTG
- Stock Information
- Founded
- TERN 2017
- ACTG 1993
- Country
- TERN United States
- ACTG United States
- Employees
- TERN N/A
- ACTG N/A
- Industry
- TERN Biotechnology: Pharmaceutical Preparations
- ACTG Multi-Sector Companies
- Sector
- TERN Health Care
- ACTG Miscellaneous
- Exchange
- TERN Nasdaq
- ACTG Nasdaq
- Market Cap
- TERN 499.4M
- ACTG 441.1M
- IPO Year
- TERN 2021
- ACTG 1996
- Fundamental
- Price
- TERN $6.80
- ACTG $4.50
- Analyst Decision
- TERN Buy
- ACTG Strong Buy
- Analyst Count
- TERN 5
- ACTG 1
- Target Price
- TERN $18.30
- ACTG $7.00
- AVG Volume (30 Days)
- TERN 1.8M
- ACTG 218.7K
- Earning Date
- TERN 11-12-2024
- ACTG 11-12-2024
- Dividend Yield
- TERN N/A
- ACTG N/A
- EPS Growth
- TERN N/A
- ACTG N/A
- EPS
- TERN N/A
- ACTG 0.39
- Revenue
- TERN N/A
- ACTG $165,779,000.00
- Revenue This Year
- TERN N/A
- ACTG N/A
- Revenue Next Year
- TERN N/A
- ACTG $84.79
- P/E Ratio
- TERN N/A
- ACTG $11.55
- Revenue Growth
- TERN N/A
- ACTG 261.08
- 52 Week Low
- TERN $4.32
- ACTG $3.65
- 52 Week High
- TERN $11.40
- ACTG $5.74
- Technical
- Relative Strength Index (RSI)
- TERN 52.65
- ACTG 48.83
- Support Level
- TERN $6.41
- ACTG $4.43
- Resistance Level
- TERN $7.14
- ACTG $4.57
- Average True Range (ATR)
- TERN 0.48
- ACTG 0.09
- MACD
- TERN 0.10
- ACTG 0.00
- Stochastic Oscillator
- TERN 59.76
- ACTG 57.14
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.
About ACTG Acacia Research Corporation (Acacia Tech)
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, significant capital base, and deep industry relationships to drive value. Acacia evaluates opportunities based on the attractiveness of the underlying cash flows, without regard to a specific investment horizon. Acacia operates its businesses based on three key principles of people, process, and performance and has built a management team with demonstrated expertise in research, transactions and execution, and operations and management.